Anti-proliferative effect of toremifene and tamoxifen on estrogen receptor-lacking anaplastic thyroid carcinoma cell lines

Biological and Pharmaceutical Bulletin

Volumn 20, Issue 12, 1997, Pages 1257-1260

  Kiskino, Tohru ^a,b   Watanabe, Masatoshi ^b   Kimura, Masayuki ^a   Sugawara, Isamu ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

Author keywords

Anaplatic thyroid carcinoma; Estrogen receptor; Insulin like growth factor 1 (IGF 1) receptor; Multidrug resistance; Toremifene

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; SOMATOMEDIN C RECEPTOR; TAMOXIFEN; TOREMIFENE;

ANAPLASTIC CARCINOMA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN MCF 7; DOSE RESPONSE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MULTIDRUG RESISTANCE; THYROID CARCINOMA;

EID: 0031452854     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.20.1257     Document Type: Article

References (23)

1. Carbone P. P., "The EORTC Cancer Chemotherapy Manual," No, 5. ed. by Pinedo H. M., Chabner B, A., Elsevier, Amsterdam, 1983 pp. 398-422.
2. Jordan V. C., Murphy C. S., Endocrine Rev., 11, 578-610 (1990).
3. Riley D., Baum M., MacIntyre J., Borstock D., McKinna A., Jackson I., Sainsbury J. R. C., Wilson A., Wheeler T., Dobbs J., Rees G., Powles T., Rubens R., Haybittle J., McPherson K., Houghton J., Eur. J. Cancer, 28A, 904-907 (1992).
4. Cuzick J., Wang D. Y., Bulbrook R. D., Lancet, i, 83-86 (1986).
5. Nayfield S. G., Karp J. E., Ford L. G., Dorr F. A., Kramer B. S., J. Natl. Cancer Inst., 83, 1450-1459 (1991).
6. Kangas L., Nieminen A-L., Blanco G., Grönroos M., Kallio S., Karjarainen A., Perilä M., Södervall M., Toivola R., Cancer Chemother. Pharmacol., 17, 109-113 (1986).
7. Yamashita T., Watanabe M., Onodera M., Shimaoka K., Ito K., Fujimoto Y., Itoyama S., Suguwura I., Cancer Detect. Prev., 18, 407-413 (1994).
8. Sugawara I., Arai T., Yamashita T., Yoshida A., Masunaga A., Itoyama S., Cancer Lett., 82, 185-188 (1994).
9. Sugawara I., Masunaga A., Itoyama S., Sumizawa T., Akiyama S., Yamashita T., Cancer Lett., 95, 135-138 (1995).
10. Sugawara I., Watanabe M., Yamashita T., Yoshida A., Itoh K., Itoyama S., Tumor Targeting, 1, 93-98 (1995).
11. Hsu S. M., Raine L., Fanger H., J. Histochem. Cytochem., 29, 577-580 (1981).
12. Sugawara I., Ohkochi E., Hamada H., Tsuruo T., Mori S., Jpn. J. Cancer Res., 19, 1101-1110 (1988).
13. Arai T., Watanabe M., Onodera M., Yamashita T., Musunaga A., Itoyama S., Sugawara I., Am. J. Pathol 142, 1938-1944 (1993).
14. Sugawara T., Watanabe M., Masunaga A., Itoyama S., Ueda K., Jpn. J. Cancer Res., 83, 131-133 (1992).
15. Croxtall J. D., Emmas C., White J. O., Choudhary Q., Flower R. J., Biochem. Pharmacol 47, 197-202 (1994).
16. Sutherland R. L., Murphy L. C., Foo M. S., Green M. D., Mhybourne A. M., Krozowski Z. S., Nature, 288, 273-275 (1980).
17. Lavie Y., Cao H. T., Volner A., Lucci A., Han T. Y., Gerten V., Giuliano A. E., Cabot M. C., J. Biol. Chem., 272, 1682-1687 (1997).
18. Valverde M. A., Bond T. D., Hardy S. P., Taylor J. C., Higgins C. F., Altamirano J., Alvarez-Leefmans F. J., EMBO J., 15, 4460-4468 (1996).
19. Hotta T., Tanimura H., Yamaue H., Iwahashi M., Tani M., Tsunoda T., Tamai M., Noguchi K., Mizobata S., Arii K., Terasawa H., J. Surg. Res., 66, 31-35 (1996).
20. Berman E., McBride M., Lin S., Menedez-Botet C., Tong W., Leukemia, 9, 1631-1637 (1995).
21. Ramu A., Glaubiger D., Fuks Z., Cancer Res., 44, 4392-4395 (1984).
22. Huynh H. T., Tetenes E., Wallace L., Pollak M., Cancer Res., 53, 1727-1730 (1993).
23. Pollak M., Huynh H., Lefebvre S., Breast Cancer Res. Treat., 22, 91-100 (1992).